December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

electroCore, Inc. - Common Stock (NQ:ECOR)

4.770 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about electroCore, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation - Which Is Better To Alleviate Concussion Symptoms ↗
electroCore, Inc.’s (NASDAQ: ECOR) gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain... 
Via Benzinga
News headline image
electroCore Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
electroCore: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
Electrocore Inc. (NASDAQ: ECOR) Near the Top of Equities by Percentage Gain on 3/24
Via Investor Brand Network
News headline image
electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study
From electroCore, Inc.
Via GlobeNewswire
News headline image
electroCore Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
A Preview Of electroCore's Earnings ↗
 
Via Benzinga
News headline image
electroCore Announces Reverse Stock Split
From electroCore, Inc.
Via GlobeNewswire
News headline image
electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury
Pre-clinical trial demonstrates the ability of nVNS to decrease the amount of brain injury, decrease anxiety and improve motor function post injury 
From electroCore, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank
From electroCore, Inc.
Via GlobeNewswire
News headline image
electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting
Poster Highlights the Ability of Non-Invasive Vagus Nerve Stimulation (nVNS) to Accelerate Learning of a Second Language 
From electroCore, Inc.
Via GlobeNewswire
News headline image
electroCore to Participate at 35th Annual Roth Conference
From electroCore, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 8, 2023 ↗
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
News headline image
electroCore Regains Compliance with Nasdaq Listing Requirements
From electroCore, Inc.
Via GlobeNewswire
News headline image
electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8
From electroCore, Inc.
Via GlobeNewswire
News headline image
7 Stocks to Sell as Borrowing Costs Rise ↗
With new economic data boding poorly for risk-on investments, investors should strongly consider targeting stocks to sell. 
Via InvestorPlace
News headline image
10 Short Squeeze Candidates: Getty Images, Genius Brands, Lannett And More ↗
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
News headline image
electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa
From electroCore, Inc.
Via GlobeNewswire
News headline image
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
From electroCore, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
electroCore Announces Expected Record 4Q 2022 Revenue of $2.5M; Provides Business Update
From electroCore, Inc.
Via GlobeNewswire
News headline image
electroCore Completes Sale of New Jersey Tax Benefits
From electroCore, Inc.
Via GlobeNewswire
News headline image
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2023 ↗
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.